Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Angel QinSongzhu ZhaoAbdul MiahLai WeiSandipkumar PatelAndrew C JohnsMadison GroganErin M BertinoKai HePeter G ShieldsGregory P KalemkerianShirish M GadgeelNithya RamnathBryan J SchneiderKhaled A HassanNicholas SzerlipZoey ChopraSara JourneyJessica WaningerDaniel J SpakowiczDavid P CarboneCarolyn J PresleyGregory A OttersonMichael D GreenDwight H OwenPublished in: Journal of the National Comprehensive Cancer Network : JNCCN (2021)
Presence of bone metastases at baseline was associated with a worse prognosis for patients with mNSCLC treated with ICI after controlling for multiple clinical characteristics. Use of BMAs was not associated with reduced SREs or a difference in survival.
Keyphrases